Accuray inks 10-year cancer tech agreement, shares in focus
Accuray Incorporated announced late Friday it’s entering a 10-year tie-up with the University of Wisconsin School of Medicine and Public Health. The two plan to work on customized cancer treatments with Accuray’s Stellar adaptive radiation therapy platform. Accuray put out the news after the Nasdaq close, a detail that mattered for the already struggling stock.